nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXA2R—artery—uterine cancer	0.177	0.278	CbGeAlD
Ridogrel—TBXAS1—myometrium—uterine cancer	0.0749	0.118	CbGeAlD
Ridogrel—TBXAS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—uterine cancer	0.0713	0.196	CbGpPWpGaD
Ridogrel—TBXA2R—epithelium—uterine cancer	0.067	0.105	CbGeAlD
Ridogrel—TBXA2R—decidua—uterine cancer	0.0633	0.0994	CbGeAlD
Ridogrel—TBXAS1—smooth muscle tissue—uterine cancer	0.0567	0.089	CbGeAlD
Ridogrel—TBXA2R—female reproductive system—uterine cancer	0.0498	0.0782	CbGeAlD
Ridogrel—TBXAS1—uterus—uterine cancer	0.0486	0.0763	CbGeAlD
Ridogrel—TBXA2R—vagina—uterine cancer	0.045	0.0707	CbGeAlD
Ridogrel—TBXAS1—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.0411	0.113	CbGpPWpGaD
Ridogrel—TBXA2R—lymph node—uterine cancer	0.0291	0.0457	CbGeAlD
Ridogrel—TBXAS1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.0258	0.0709	CbGpPWpGaD
Ridogrel—TBXAS1—lymph node—uterine cancer	0.0256	0.0402	CbGeAlD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.0236	0.0649	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.0191	0.0526	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.0173	0.0477	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.0141	0.0387	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—CYP11A1—uterine cancer	0.0102	0.0279	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00901	0.0248	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—CYP19A1—uterine cancer	0.00747	0.0205	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00652	0.0179	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00652	0.0179	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00478	0.0132	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NDUFB11—uterine cancer	0.00401	0.011	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SRD5A2—uterine cancer	0.00401	0.011	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.0039	0.0107	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00368	0.0101	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—AKT1—uterine cancer	0.00357	0.00982	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (12/13) signalling events—PIK3CA—uterine cancer	0.00346	0.00952	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IRF1—uterine cancer	0.00325	0.00895	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKR1B1—uterine cancer	0.0029	0.00798	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—STAR—uterine cancer	0.0029	0.00798	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.00287	0.00789	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—POLD1—uterine cancer	0.00228	0.00626	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.0022	0.00605	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKR1C1—uterine cancer	0.00213	0.00586	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKR1B10—uterine cancer	0.00211	0.00581	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—RRM2—uterine cancer	0.0019	0.00522	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	0.00188	0.00518	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.00187	0.00513	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—DCN—uterine cancer	0.00184	0.00507	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RNF43—uterine cancer	0.00175	0.00481	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.00174	0.00479	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP11A1—uterine cancer	0.00174	0.00478	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CCL2—uterine cancer	0.00168	0.00461	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—PIK3CA—uterine cancer	0.00167	0.00458	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKR1C3—uterine cancer	0.00164	0.00451	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	0.00162	0.00446	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—INHBA—uterine cancer	0.0016	0.0044	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.00149	0.0041	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.00146	0.00401	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKR1C1—uterine cancer	0.00144	0.00396	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.00138	0.00379	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL8—uterine cancer	0.00132	0.00364	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—STK11—uterine cancer	0.00128	0.00351	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP19A1—uterine cancer	0.00128	0.00351	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.0012	0.0033	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—AKT1—uterine cancer	0.00119	0.00328	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.00114	0.00315	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKR1C3—uterine cancer	0.00111	0.00305	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PGR—uterine cancer	0.00108	0.00297	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—YWHAE—uterine cancer	0.00103	0.00284	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—EP300—uterine cancer	0.00102	0.00279	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FBXW7—uterine cancer	0.000988	0.00272	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VEGFA—uterine cancer	0.000962	0.00265	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTHFR—uterine cancer	0.00096	0.00264	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NRAS—uterine cancer	0.00095	0.00261	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STK11—uterine cancer	0.000864	0.00238	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CCL2—uterine cancer	0.00086	0.00237	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000846	0.00233	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—KRAS—uterine cancer	0.000818	0.00225	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SOCS3—uterine cancer	0.000809	0.00222	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN2B—uterine cancer	0.000774	0.00213	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IGF1R—uterine cancer	0.000752	0.00207	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CA—uterine cancer	0.000752	0.00207	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL8—uterine cancer	0.000749	0.00206	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TP53—uterine cancer	0.000727	0.002	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SMAD3—uterine cancer	0.000707	0.00194	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—HRAS—uterine cancer	0.000695	0.00191	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL8—uterine cancer	0.00068	0.00187	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGFR2—uterine cancer	0.000674	0.00185	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—AKT1—uterine cancer	0.000614	0.00169	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ESR1—uterine cancer	0.000577	0.00159	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—NRAS—uterine cancer	0.000545	0.0015	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTEN—uterine cancer	0.000534	0.00147	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—EP300—uterine cancer	0.000509	0.0014	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL2—uterine cancer	0.000508	0.0014	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CA—uterine cancer	0.000475	0.00131	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—KRAS—uterine cancer	0.000469	0.00129	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CA—uterine cancer	0.000431	0.00119	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ERBB2—uterine cancer	0.000424	0.00116	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL8—uterine cancer	0.000402	0.0011	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—HRAS—uterine cancer	0.000399	0.0011	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1B—uterine cancer	0.000392	0.00108	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AKT1—uterine cancer	0.000388	0.00107	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CA—uterine cancer	0.000377	0.00104	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CTNNB1—uterine cancer	0.000371	0.00102	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTEN—uterine cancer	0.000361	0.000993	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AKT1—uterine cancer	0.000352	0.000969	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EP300—uterine cancer	0.000344	0.000947	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VEGFA—uterine cancer	0.000326	0.000897	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NRAS—uterine cancer	0.000322	0.000886	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKT1—uterine cancer	0.000308	0.000847	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KRAS—uterine cancer	0.000277	0.000763	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CA—uterine cancer	0.000255	0.000701	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TP53—uterine cancer	0.000246	0.000678	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HRAS—uterine cancer	0.000236	0.000648	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKT1—uterine cancer	0.000208	0.000572	CbGpPWpGaD
